I'm thinking 6.5x EBITDA will be somewhere around the 3.20 mark when the results come out. Just my opinion as I think they are going to have issues hitting their forecast with the ongoing drought and China problems with the products integration.
If debt levels are normalized to circa 2.0x - 2.5x EBITDA, I would buy in at that valuation. Wait for upside of a good harvest & a fully integration product line to boost earnings and sentiment over FY20/FY21. All a gamble but at least there would be a good margin of safety, how much more can go wrong!
NUF, page-93
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.61 |
Change
0.080(1.77%) |
Mkt cap ! $1.762B | |||
| Open | High | Low | Value | Volume |
| $4.55 | $4.63 | $4.55 | $2.876M | 625.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6369 | $4.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.61 | 683 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NUF (ASX) Chart |